Moderna (MRNA) Treasury Shares (2017 - 2025)
Moderna (MRNA) posted quarterly Treasury Shares of $11.2 million for Q4 2025, up 42.49% year-over-year from $7.9 million in Q4 2024, and up 42.49% on a QoQ basis from $7.9 million in Q4 2024.
Moderna (MRNA) Treasury Shares (2017 - 2025) Analysis & Trends
Moderna has reported Treasury Shares for 8 years, with the latest figure at $11.2 million in Q4 2025.
- Treasury Shares for Q4 2025 came in at $11.2 million, up 42.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.2 million (up 42.49% YoY), and the FY2025 annual result was $11.2 million, up 42.49% from the prior year.
- Treasury Shares rose to $11.2 million in Q4 2025, from $7.9 million in the prior quarter.
- Over five years, Treasury Shares peaked at $11.2 million in Q4 2025 and troughed at $2.1 million in Q4 2021.
- A 5-year average of $4.5 million and a median of $2.6 million in 2021 frame the typical range for Treasury Shares.
- The widest annual swing landed in 2021, when Treasury Shares decreased 2.28%; it then jumped 78.62% in 2023.
- A 5-year view of Treasury Shares shows it stood at $2.1 million in 2021, then jumped by 35.51% to $2.9 million in 2022, then jumped by 78.62% to $5.2 million in 2023, then soared by 51.74% to $7.9 million in 2024, then surged by 42.49% to $11.2 million in 2025.
- Per Business Quant data, the three most recent Treasury Shares figures were $11.2 million in Q4 2025, $7.9 million in Q4 2024, and $5.2 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.20 Mn |
| Dec 31, 2025 | 11.20 Mn |
| Dec 31, 2024 | 7.86 Mn |
| Dec 31, 2024 | 7.86 Mn |
| Dec 31, 2023 | 5.18 Mn |
| Dec 31, 2023 | 5.18 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Dec 31, 2022 | 2.90 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Dec 31, 2021 | 2.14 Mn |
| Sep 30, 2021 | 2.24 Mn |
| Sep 30, 2021 | 2.24 Mn |
| Jun 30, 2021 | 2.32 Mn |
| Jun 30, 2021 | 2.32 Mn |
| Mar 31, 2021 | 2.39 Mn |
| Mar 31, 2021 | 2.39 Mn |
| Dec 31, 2020 | 2.19 Mn |
| Dec 31, 2020 | 2.19 Mn |
| Sep 30, 2020 | 2.17 Mn |
| Sep 30, 2020 | 2.17 Mn |